Yesil Science / Blog
Blog
Every article we have published: research summaries, product thinking and developments in health AI.
Latest articles

Local AI clinical notes require strict schema enforcement
Forcing local clinical AI models to follow strict formatting rules stops software crashes but does not guarantee safe medical editing.

Can AI replace animal testing in five years?
The UK is betting £75 million that algorithms can replace animals in drug safety trials, but the regulatory hurdles remain immense.

Four Brain Bleed AI Tools Compared in ER
Hospital buyers assume all top-tier radiology AI performs the same, but new head-to-head data reveals critical trade-offs that could compromise patient care...

FDA Clears Philips AI Ultrasound Software
Automating the routine mechanics of ultrasound exams is no longer a luxury; it is becoming a survival strategy for short-staffed clinics.

AI predicts late breast cancer recurrence risk
A new multimodal AI model helps solve the agonizing clinical dilemma of whether breast cancer survivors should endure five extra years of...

AI Medicare Denials Are Here to Stay
A Senate vote keeping an AI-driven Medicare pilot alive reveals a dangerous shift toward automated care denials.

Grading the Algorithms That Guide Bedside Medicine
Clinical calculators dictate life-or-death medical decisions every day, but doctors have had no objective way to know which algorithms are actually safe...

MedSafe-Dx (v0): A Safety-Focused Benchmark for Evaluating LLMs in Clinical Diagnostic Decision Support
A new benchmark reveals that today's best artificial intelligence models only look safe in the clinic because they constantly cry wolf.

Eli Lilly Bets on Oura Rings
Pharmaceutical giants are realizing that selling a weight-loss drug is only half the battle.

AI detects abnormal child growth years earlier
A new algorithm spots rare growth disorders years before traditional clinical methods, shifting the focus of pediatric screening from reactive tracking to...

AI Drug Discovery Targets the Factory Floor
A new joint venture is shifting AI's role from designing molecules to actually building them at scale.

AI synthetic patients successfully replace real trial controls
A new study shows AI-generated synthetic patients can replicate cancer trial results, potentially shrinking the need for human control groups.
Also on LinkedIn
AI Health Hub posts the same research summaries on LinkedIn every day. More than 3,000 people follow it there.